Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Bacteremia or Infant, Very Low Birth Weight
and you are
between 24 and 29
years old
The phase for this study is not defined.
Show me locations

The purpose

This study evaluates the potential interest of a new multi-lumen infusion access device (Edelvaiss® Multiline NEO) in the prevention of catheter-related bacteremia when administering injectable drugs in premature infants. This device will be compared to the standard infusion set of each center.

Provided treatments

  • Device: Edelvaiss Multiline NEO
  • Device: Standard Infusion Set
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02633124. The sponsor of the trial is University Hospital, Lille and it is looking for 280 volunteers for the current phase.
Official trial title:
Preventing Catheter-related Bacteremia When Administering Injectable Medications in Premature Infants: Randomized Controlled Multicenter Study of Edelvaiss Multiline NEO Device